LegisTrack
Back to all bills
HR 4019119th CongressIn Committee

Gio’s Law

Introduced: Jun 17, 2025
Technology & Innovation
Standard Summary
Comprehensive overview in 1-2 paragraphs

Gio’s Law would create a new grant program under the Omnibus Crime Control and Safe Streets Act to help state, local, and tribal law enforcement agencies access epinephrine products and training. The bill requires the Attorney General to develop or select standardized training so officers can recognize symptoms of anaphylaxis and correctly administer epinephrine to someone believed to be having an allergic reaction. It also establishes civil liability protections for officers who administer epinephrine and sets up an application process for grants to purchase epinephrine products and fund training. The bill authorizes $25 million annually for 2026–2030 to fund these activities, requires annual reporting on epinephrine administration by law enforcement, and directs an interagency public awareness campaign to educate the public about anaphylaxis and the role of police and first responders. Key definitions include epinephrine auto-injectors and other non-injection forms of epinephrine administration. The Act also requires accountability measures, such as certification from a state attorney general that officers are protected from civil liability when administering epinephrine.

Key Points

  • 1Establishes a new grant program (Part PP) under Title I to fund the purchase of epinephrine products and training for state, local, and tribal law enforcement agencies.
  • 2Mandates development or identification of standardized training within 180 days, focusing on recognizing anaphylaxis and properly administering epinephrine in suspected cases.
  • 3Requires grant applications to include a certification that officers are protected from civil liability for administering epinephrine.
  • 4Defines epinephrine product to include auto-injectors and other administrative methods beyond injection.
  • 5Authorizes $25 million per year for 2026–2030 to carry out the program, plus annual reporting by the Bureau of Justice Statistics on how often law enforcement administers epinephrine, and an interagency public awareness campaign with the Department of Health and Human Services.

Impact Areas

Primary group/area affected: State, local, and tribal law enforcement agencies and the public they serve, particularly individuals at risk of anaphylaxis who may encounter officers in emergencies.Secondary group/area affected: Federal, state, and local governments funding agencies; Bureau of Justice Statistics (data reporting); Department of Health and Human Services (communications/public awareness efforts).Additional impacts: Standardized training could influence police protocols, liability considerations for officers and departments, and data collection about epinephrine administration in enforcement encounters. The public awareness campaign may affect general knowledge about anaphylaxis and the role of law enforcement in emergency care.
Generated by gpt-5-nano on Oct 7, 2025